Nutrien delivered a solid operational quarter with record potash volumes and strong free cash flow generation. The raised potash volume guidance and lowered capex are incremental positives, while the phosphate margin compression is a known headwind. The stock's recent weakness (down ~9% at T+20 on prior neutral reads) may be overdone given improving fundamentals — watch for the earnings call on August 6 for commentary on phosphate strategy and geopolitical impacts on nitrogen.
Price Chart
Executive Summary
Nutrien reported Q2 2026 net earnings of $1.22B ($2.53 diluted EPS) on revenue of $10.81B, with adjusted EBITDA of $2.43B and adjusted EPS of $2.61. First-half results showed record potash sales volumes, strong proprietary products margins, and 12% operating cash flow growth. Guidance was modestly updated: potash volume guidance raised to 14.2-14.8M tonnes and capital expenditure guidance lowered to $1.95-2.05B, while other metrics were unchanged. Q2 comparisons showed slight net earnings decline (-1%) and adjusted EBITDA decline (-2%) YoY as higher fertilizer benchmarks were offset by lower volumes and higher sulfur costs, but the stronger first-half trajectory and increased shareholder returns ($848M returned in H1, up 8% YoY) provide a generally positive read.
Key Facts
- Q2 2026 revenue: $10.81B (+4% YoY); Q2 net earnings: $1.22B (-1% YoY); Q2 adjusted EBITDA: $2.43B (-2% YoY)
- Q2 diluted EPS: $2.53 (+1% YoY); Q2 adjusted EPS: $2.61 (-2% YoY)
- First-half 2026 revenue: $16.86B (+8% YoY); H1 net earnings: $1.36B (+9% YoY); H1 adjusted EBITDA: $3.54B (+6% YoY)
- H1 diluted EPS: $2.80 (+11% YoY); H1 adjusted EPS: $3.11 (+13% YoY)
- Potash: H1 adjusted EBITDA $1.24B (+15% YoY) on record first-half sales volumes (7.45M tonnes) and higher global benchmarks
- Nitrogen: H1 adjusted EBITDA $1.12B (+4% YoY) driven by higher benchmarks and lower natural gas costs
- Retail: H1 adjusted EBITDA $1.24B (+4% YoY) on higher proprietary products margins and strong Australia livestock market
- Phosphate: Q2 adjusted EBITDA collapsed 75% to $23M; H1 down 48% to $80M on elevated sulfur input costs
- Guidance: Potash sales volumes raised to 14.2-14.8M tonnes (from 14.1-14.8M); capex lowered to $1.95-2.05B (from $2.0-2.1B); Retail adjusted EBITDA guidance unchanged at $1.75-1.95B
- Cash provided by operating activities H1: $1.63B (+12% YoY); returned $848M to shareholders via dividends and buybacks (+8% YoY)
- Since June 2026, entered agreements to sell non-core assets for ~$90M; ~$1B divested since Q4 2024
Financial Impact
Nutrien's Q2 results were slightly below Q2 2025 on the top-line comparable but H1 shows solid 6-13% growth in adjusted EBITDA/EPS. The raised potash guidance and lowered capex are incrementally positive. The phosphate business remains a drag, but overall the company is generating strong free cash flow and returning more to shareholders.
Risk Factors
- Continued phosphate margin compression due to elevated sulfur costs and constrained feedstock availability
- Geopolitical uncertainty and trade flow disruptions impacting nitrogen and potash benchmark prices
- Lower Q2 nitrogen volumes due to plant shutdowns (Trinidad, New Madrid) and deferred customer purchases
- Sensitivity to global crop prices and grower affordability, particularly in Brazil
- Higher restructuring costs ($82M in H1 vs $22M in H1 2025) tied to portfolio optimization
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-335517 |
| Document: d129364dex993.htm | 0001193125-26-335517 |
| Document: d129364dex992.htm | 0001193125-26-335517 |
| Document: d129364d6k.htm | 0001193125-26-335517 |
| Document: 0001193125-26-335517-index-headers.html | 0001193125-26-335517 |
| Document: 0001193125-26-335517-index.html | 0001193125-26-335517 |
| Document: 0001193125-26-335517.txt | 0001193125-26-335517 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 6-K | $66.76 $80.73 | ▲ +20.93% | ▲ +20.33% | $70.06 (+4.94%) |
May 29, 2026 17w ago | 6-K | $69.57 $62.95 | ▼ −9.52% | ▼ −8.22% | $70.06 (+0.70%) |
May 27, 2026 18w ago | 6-K | $69.65 $60.98 | ▼ −12.45% | ▼ −9.30% | $70.06 (+0.59%) |
May 7, 2026 21w ago | 6-K | $68.38 $68.81 | ▲ +0.63% | ▼ −2.51% | $70.06 (+2.46%) |
Mar 30, 2026 26w ago | Court Ruling | $76.00 $72.91 | ▼ −4.07% | ▼ −16.66% | $70.06 (−7.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access